Horikawa Izumi, Cable P LouAnn, Mazur Sharlyn J, Appella Ettore, Afshari Cynthia A, Barrett J Carl
Laboratory of Biosystems and Cancer, Cancer and Aging Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Mol Biol Cell. 2002 Aug;13(8):2585-97. doi: 10.1091/mbc.e01-11-0107.
Regulation of the hTERT gene encoding the telomerase catalytic subunit plays an important role in human cell senescence, immortalization, and carcinogenesis. By examining the activity of various deleted or mutated hTERT promoter fragments, we show that an E-box element downstream of the transcription initiation site is critical to differential hTERT transcription between the telomerase/hTERT-positive renal cell carcinoma cell line (RCC23) and its telomerase/hTERT-negative counterpart containing a transferred, normal chromosome 3 (RCC23+3). This E-box element mediated repression of hTERT transcription in RCC23+3 but not in RCC23. A copy number-dependent enhancement of the repression suggested active repression, rather than loss of activation, in RCC23+3. Endogenous expression levels of c-Myc or Mad1, which could activate or repress hTERT transcription when overexpressed, did not account for the differential hTERT transcription. Gel mobility shift assays identified the upstream stimulatory factors (USFs) as a major E-box-binding protein complex in both RCC23 and RCC23+3 and, importantly, detected an RCC23+3-specific, E-box-binding factor that was distinct from the USF and Myc/Mad families. The E-box-mediated repression was also active in normal human fibroblasts and epithelial cells and inactive in some, but not all, telomerase/hTERT-positive cancer cells. These findings provide evidence for an endogenous, repressive mechanism that actively functions in telomerase/hTERT-negative normal cells and becomes defective during carcinogenic processes, e.g., by an inactivation of the telomerase repressor gene on chromosome 3.
编码端粒酶催化亚基的hTERT基因的调控在人类细胞衰老、永生化及癌变过程中发挥着重要作用。通过检测各种缺失或突变的hTERT启动子片段的活性,我们发现转录起始位点下游的一个E盒元件对于端粒酶/hTERT阳性肾癌细胞系(RCC23)及其含有转入的正常3号染色体的端粒酶/hTERT阴性对应细胞系(RCC23+3)之间hTERT的差异转录至关重要。这个E盒元件介导了RCC23+3中hTERT转录的抑制,但在RCC23中却没有。这种抑制作用的拷贝数依赖性增强表明在RCC23+3中存在主动抑制,而非激活缺失。过表达时可激活或抑制hTERT转录的c-Myc或Mad1的内源性表达水平并不能解释hTERT的差异转录。凝胶迁移率变动分析确定上游刺激因子(USFs)是RCC23和RCC23+3中主要的E盒结合蛋白复合物,重要的是,检测到一种与USF及Myc/Mad家族不同的RCC23+3特异性E盒结合因子。E盒介导的抑制在正常人成纤维细胞和上皮细胞中也具有活性,而在一些(但不是全部)端粒酶/hTERT阳性癌细胞中无活性。这些发现为一种内源性抑制机制提供了证据,该机制在端粒酶/hTERT阴性正常细胞中发挥积极作用,并在致癌过程中例如通过3号染色体上的端粒酶抑制基因失活而出现缺陷。